Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US

Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US
Health experts are concerned by the simultaneous spread of three respiratory illnesses in the United States. (Photo: Getty)
Dan Brunskill
Fisher & Paykel Healthcare has reported half-year earnings ahead of analyst expectations and their own market guidance, with operating revenue at $690.6 million.The company had told the market to expect revenue to be $670m in its August trading update, warning that many customers were already stocked up on hospital products.Even though the higher-than-expected revenue was 23% lower than in the first half of the prior year, it was a 21% increase on the pre-pandemic period first half of 2020.Fisher & Paykel Healthcare's (FPH) chief ex...

More Markets

Thinking of investing? Skip 'most' of NZX
Opinion

Simon Robertson: Thinking of investing? Skip 'most' of NZX

If you want to grow your wealth, then buy the S&P 500. Period.

Simon Robertson 06 Dec 2025
Fisher and Paykel Healthcare drives NZ stocks to weaker finish
Markets Market Close

Fisher and Paykel Healthcare drives NZ stocks to weaker finish

The S&P/NZX 50 Index closed down 31.63 points, or 0.23%, to 13,483.99.

Jamie Gray 05 Dec 2025
Fletcher Building extends bank covenant deal
Markets

Fletcher Building extends bank covenant deal

The company cannot pay a dividend until it meets its standard covenant levels.

Rebecca Howard 05 Dec 2025
The small standout performers on the NZX
Retail Small Cap Wrap

The small standout performers on the NZX

The small cap index has a blinder in 2025, some small cap awards, and more.